InvestorsHub Logo
Followers 3
Posts 195
Boards Moderated 1
Alias Born 10/28/2009

Re: geodan post# 4440

Wednesday, 08/18/2010 7:46:25 AM

Wednesday, August 18, 2010 7:46:25 AM

Post# of 5204
Great job. Your observations are clear and a lot of what I use when making my initial investments in both these companies...I have 5x as much XCHO compared to NPHC...with a lot based on the cost of marketing v. R+D. Also, revenues were obviously going to be substantially higher for XCHO. If individuals don't know how supplier/distributor revenues are different, they should stay out of this sector.

At this point, the jury is still out on both of these. We absolutely must have the marketing work. If that occurs, sales will increase and all will be happy. If not, the only product XCHO has that is generating revenue will be lost and NPHC will fall victim to most start-up biotechs and run out of cash. It's not over yet by any means but must be watched closely.

JMHO

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.